GCM
ANGO icon

Gladius Capital Management’s AngioDynamics ANGO Stock Holding History

Gladius Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,080
Closed -$30.7K – 286
2024
Q2 		$30.7K Sell
5,080
-790
-13% -$4.88K ﹤0.01% 245
2024
Q1 		$34.5K Buy
5,870
+781
+15% +$4.64K 0.01% 269
2023
Q4 		$39.9K Buy
5,089
+969
+24% +$6.72K 0.01% 209
2023
Q3 		$30.1K Buy
+4,120
New +$34.3K ﹤0.01% 300

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gladius Capital Management's ANGO Position: Q3 2024 in Review

Gladius Capital Management sold out of AngioDynamics (ANGO) in Q3 2024, closing a stake of 5,080 shares — an estimated $30.7K sold.

Gladius Capital Management first reported a position in ANGO in Q3 2023 and held it in 4 quarters. The position peaked at $39.9K in Q4 2023. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2024.

  • Gladius Capital Management reported no remaining AngioDynamics position as of Q3 2024 after selling out during the quarter.
  • Gladius Capital Management sold 5,080 AngioDynamics shares in Q3 2024, an estimated $30.7K.
  • Gladius Capital Management first reported a position in AngioDynamics in Q3 2023 and held it in 4 quarters.
  • Gladius Capital Management's AngioDynamics position peaked at $39.9K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.